BCR-ABL1 Qpcr-Based Doubling Time Within the First 6 Months after Imatinib Discontinuation is a Predictive of Successful TKI Treatment-Free RemissionGeorgina S. Daher-Reyes,Isabelle Bence-Bruckler,Lambert Busque,Donna L. Forrest,Lynn Savoie,Mary-Margaret Keating,Robert Delage,Anargyros Xenocostas,Elena Liew,Pierre Laneuville,Kristjan Paulson,Jeffrey H. Lipton,Suzanne Kamel-Reid,Brian Leber,Dennis Dong Hwan KimBLOOD（2019）引用 1|浏览64暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
